Irritable Bowel Syndrome
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
7/1/2018: 12:00 AM
Ends On:
6/30/2019: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.75
Description:
Instructor in Pediatrics
Pediatric Gastroenterology
Disclosures: No financial relationships to disclose.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Pediatric Early Bird Rounds, April 7, 2017, which is supported by St. Louis Children's Hospital.
David A. Hunstad, MD
Current Position: Assistant Professor, Pediatrics / Division of Infectious Diseases Assistant Professor, Molecular Microbiology
Disclosure: Consulting: Board of Directors, BioVersys AG, Basel, Switzerland
Paula Murphy, RN, BSN, MBA
Current Position: Senior Physician Liaison
Disclosures: No financial relationships to disclose.
Faculty
Shannon M. Joerger, MDInstructor in Pediatrics
Pediatric Gastroenterology
Disclosures: No financial relationships to disclose.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Pediatric Early Bird Rounds, April 7, 2017, which is supported by St. Louis Children's Hospital.
Planning Committee
David A. Hunstad, MD
Current Position: Assistant Professor, Pediatrics / Division of Infectious Diseases Assistant Professor, Molecular Microbiology
Disclosure: Consulting: Board of Directors, BioVersys AG, Basel, Switzerland
Paula Murphy, RN, BSN, MBA
Current Position: Senior Physician Liaison
Disclosures: No financial relationships to disclose.
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Review the presentation and diagnosis of irritable bowel syndrome in children and adolescents.
- Discuss the potential treatment options for pediatric patients with IBS.
Additional Information:
Target Audience: This course is designed for Pediatricians, family and emergency physicians, physician assistants, nurse practitioners and other allied health professionals who encounter pediatric patients in a health care setting.
Date
Publication Date: July 1, 2018
Expiration Date: June 30, 2019
Target Audience: This course is designed for Pediatricians, family and emergency physicians, physician assistants, nurse practitioners and other allied health professionals who encounter pediatric patients in a health care setting.
Date
Publication Date: July 1, 2018
Expiration Date: June 30, 2019
Accreditation Information:
In support of improving patient care, this activity has been planned and implemented by St. Louis Children's Hospital and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity:
In support of improving patient care, this activity has been planned and implemented by St. Louis Children's Hospital and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity:
Credit Statement:
AMA Credit
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
- Hyams, J. et al. Gastroenterology 2016;150:1456-1468
- Hubbard CS et al. Plos ONE 11(5).
- Lacy, B. et al. Gastroenterology. Vol 150:6. May 2016:1393-1407
- Chey, WD. et al. JAMA. 2015;313 (9):949-958.
- Martin AE, et al. Cochrane Database of Systematic Reviews 2017, Issue 3.Art.No.:CD010973
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Category:
SLCH Series: CMEasy
